Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...

Charles River Laboratories on Wednesday beat fourth-quarter profit and revenue estimates, helped by stable demand for its drug discovery and development services from biotech clients.

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

Speaking about IIT Guwahati's commitment to developing cutting-edge biotechnologies, Prof. Devendra Jalihal, Director, IIT Guwahati, said, "IIT Guwahati is committed to advancing research that creates ...

Scientists in Japan have developed a robotic hand eerily reminiscent of The Terminator. The innovation marks a major step ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

Lab services company Charles River Laboratories (NYSE:CRL) reported Q4 CY2024 results , but sales fell by 1.1% year on year ...

StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the stock. Trinity Biotech Price ...